DREAM Scientist Dr. Kristy Wittmeier (@kristywittmeier) contributed two important papers related to patient engagement this past month. Patient engagement and advisory contributions are critical to designing studies that are relevant to the patient populations being studied. Dr. Wittmeier and her colleagues at the George and Fay Yee Centre for Healthcare Innovation have published two important papers in this area that could influence research for youth living with or at risk

Dr. Paul Fernyhough and his team discover benefits of insulin extend beyond glucose. Using an animal model of type 1 diabetes, Dr. Fernyhough and his team examined the impact of insulin therapy on nerve cells (dorsal root ganglia) that are involved in diabetes-related neuropathy and the mitochondrial pathways that provide energy for these cells. After treating the animal model of type 1 diabetes with 10nM of insulin nerve function was restored and these positive effects were

Dr Allison Dart and members of DREAM advisory committee Dr Barry Lavallee and Caroline Chartrand discover that screening for chronic kidney disease is a cost effective approach for detecting renal disease. CLICK HERE to read more. Members of the FINISHED project (http://www.kidneyhealth.ca/wp/about-us/projects/finished-project/finishedcomm/) performed screening in rural and remote Indigenous communities in Northern Manitoba. In collaboration with the Diabetes Integration Proj

DREAM theme co-lead, Dr. Jon McGavock, and DREAM affiliated AYMP Study highlighted in recent Diabetes Action Canada Newsletter CLICK HERE to view the newsletter!